Pentwater Capital Management LP, 10% Owner at Tobira Therapeutics, Inc. (TBRA), bought 105,000 shares at $39.09 ($4.1M) on 2016-09-23, disclosed to the SEC on 2016-09-23.
Open-market purchase of $4.1M TBRA by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $39.09 | 5,000 | $195K | 4.8% |
| 2 | $39.09 | 5,000 | $195K | 4.8% |
| 3 | $39.19 | 95,000 | $3.7M | 90.5% |
| Total | $39.18 avg | 105,000 | $4.1M | 100% |
| Filing → |
| CAR | SELL | 2026-04-28 | $223.1M | — | Filing → |
| CAR | BUY | 2026-02-24 | $80.1M | — | Filing → |
| TBRA | BUY | 2016-11-02 | $628K | — | Filing → |